About
designing a better life
We go beyond measuring health to build better lives through data
We deliver solutions that add value to businesses and society
easy and quick health management
Deepmedi's vision is to enable easy and fast
health measurement and management anytime, anywhere,
improving access to healthcare
we build a healthier society
We support the health management of patients with chronic conditions and use the collected data
to collaborate with partners across insurance, pharma, and more
with the goal of building a healthier society
and shape the future
- 2027
Global clinical preparation and
PMDA approval - 2028
Global market
entry and expansion - 2029
Next-generation technology and
continuous innovation
- 2026
- 01Approval of contactless blood pressure measurement software as a digital medical device
- 02ISO 27001 certification for information security management system
- 2025
- 01Excellence Award at the Safety Industry Innovation Awards (K-SAFETY AWARDS)
- 02Participated in Japan IT Week Autumn
- 03Technology presentation at the 16th Korean Society of Polar Medicine
- 04Excellence Award at the Safety Industry Innovation Awards
- 05Sejong City AI-based digital healthcare service demonstration project
- 06C-Lab Outside 7th Cohort
- 07MFDS approval of clinical trial for contactless blood pressure measurement software
- 08Blood pressure estimation algorithm published in
Nature Communications, a world-renowned journal
- 2024
- 01Developed sensor-display biomarker extraction technology
- 02Pre-A investment from a private investment association
- 03Participated in Japan IT Week Spring
- 04Entered the elderly care platform business with NHN WaPlat
- 05Selected for the IITP Limit-Challenge R&D Project
- 06Development of sensor display-based biomarker extraction technology
- 07Participated in CES 2024
- 2023
- 01Grand Prize in the Healthcare category at the 9th Korea Leading Company Awards
- 02Approval of camera-based contactless pulse wave analysis software medical device
- 2022
- 01World's first approval of camera-based blood pressure measurement software medical device
(Class II portable blood pressure measurement software medical device) - 02Launched camera-based contactless health measurement solution
- 01World's first approval of camera-based blood pressure measurement software medical device
- 2021
- 01Selected as one of Korea's top 100 promising AI companies
- 02Obtained software medical device GMP certification
- 2020
- 01Won the Johnson & Johnson QuickFire Challenge
- 2019
- 01Deepmedi selected for the Google Startup Campus training program
- 02Secured Pre-A investment from Samsung Venture Investment
- 03Selected as a Hanwha DreamPlus company
- 04MOU with MetLife
- 05Selected as a leading company in the AI processing category by the Korea Software Industry Association
- 2018
- 01Venture business certification
- 02Deepmedi selected for the Bayer Grants4Apps program
- 03Official API launch
- 04API service contract with an insurance company
- 2017
- 01Founded Deepmedi
- 02Grand Prize at the 6th Chung Ju-yung Startup Competition
- 03President's Award at the GIST National Startup Idea Competition
- 04Seed investment
- 05Secured investment from NAVER
Market Size & Growth Potential* Based on 2024
The global digital biomarker market
is projected to grow from about USD 4.2 billion in 2024,
driven by technological advances and rising healthcare demand,
to about USD 9.5 billion by 2028.
we bring to the table
Data ReliabilityMarket ShareComp. CComp. AComp. B- Innovative Technology
Powered by the latest AI, we deliver more reliable
digital biomarker data than our competitors - Fast Commercialization
Powered by the latest AI, we deliver more reliable
digital biomarker data than our competitors - Tailored Customer Service
We offer tailored solutions based on a contactless
digital biomarker SDK with a user-friendly experience - Medical Device Certification & Partnerships
With medical device licenses and strategic global
partnerships, we strengthen scalability